Medicare Procedure and Patient Information
2018 Medicare Procedure Volume
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 11 |
|---|
Dr. Zoe Eloise Quandt, Endocrinology, MD is an internist in San Francisco, CA specializing in internal medicine (adult medicine) and endocrinology. She graduated from University of California, San Francisco (UCSF), School of Medicine. Dr. Zoe Eloise Quandt, Endocrinology, MD is affiliated with Regents of the University of California, UCSF Health, UCSF Medical Group and Hill Physicians.
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 11 |
|---|
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 38 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 12 |
|---|---|
| Female | 15 |
| From 65 to 74 | 15 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated during 2019 were hypertension and high cholesterol.
| Hypertension | 44 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 99 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 27 |
|---|---|
| Female | 27 |
| Non-Hispanic White | 36 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 27 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 16 |
The most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated during 2020 were hypertension, chronic kidney disease, high cholesterol and osteoperosis.
| Hypertension | 56 |
|---|---|
| High Cholesterol | 37 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 39 |
| Asthma | 0 |
| Osteoperosis | 35 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 24 |
| Dementia | 0 |
| Cancer | 24 |
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 74 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 29 |
|---|---|
| Female | 24 |
| Non-Hispanic White | 40 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 26 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 16 |
The most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and osteoperosis.
| Hypertension | 57 |
|---|---|
| High Cholesterol | 45 |
| Stroke | 0 |
| Ischemic Heart Disease | 34 |
| Depression | 23 |
| Chronic Kidney Disease | 42 |
| Asthma | 0 |
| Osteoperosis | 40 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 28 |
| Dementia | 0 |
| Cancer | 26 |
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 146 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 32 |
|---|---|
| Female | 33 |
| Non-Hispanic White | 48 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 37 |
|---|---|
| From 75 to 84 | 15 |
| 85 and over | 0 |
| Less than 65 | 13 |
The most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated during 2022 were high cholesterol, hypertension, osteoperosis and cancer.
| Hypertension | 58 |
|---|---|
| High Cholesterol | 62 |
| Stroke | 0 |
| Ischemic Heart Disease | 22 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 17 |
| Osteoperosis | 38 |
| Atrial Fibrilation | 17 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 31 |
| Dementia | 0 |
| Cancer | 37 |
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 122 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 39 |
|---|---|
| Female | 39 |
| Non-Hispanic White | 53 |
|---|---|
| Black | 0 |
| Hispanic | 11 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 43 |
|---|---|
| From 75 to 84 | 21 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated during 2023 were high cholesterol, hypertension, diabetes and cancer.
| Hypertension | 65 |
|---|---|
| High Cholesterol | 69 |
| Stroke | 0 |
| Ischemic Heart Disease | 31 |
| Depression | 18 |
| Chronic Kidney Disease | 28 |
| Asthma | 17 |
| Osteoperosis | 33 |
| Atrial Fibrilation | 24 |
| Heart Failure | 18 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 40 |
| Dementia | 0 |
| Cancer | 37 |
Volume of procedures performed by Dr. Zoe Eloise Quandt, Endocrinology, MD for Medicare patients.
| doctor visit | 81 |
|---|
Information about Medicare patients treated by Dr. Zoe Eloise Quandt, Endocrinology, MD.
| Male | 23 |
|---|---|
| Female | 23 |
| Black / African American | 0 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 29 |
| Native American / Alaskan Native | 0 |
| Hispanic | 1 |
| Other | 0 |
| 75 to 84 | 6 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 7 |
| 65 to 74 | 24 |
The highest averages of the most common conditions of Medicare patients that Dr. Zoe Eloise Quandt, Endocrinology, MD treated were hypertension, high cholesterol, osteoperosis and cancer.
| Hypertension | 46 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 0 |
| Ischemic Heart Disease | 14 |
| Depression | 6 |
| Chronic Kidney Disease | 18 |
| Asthma | 5 |
| Osteoporosis | 24 |
| Heart Failure | 3 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 20 |
| Atrial Fibrillation | 6 |
| Cancer | 20 |
| Dementia | 0 |
Dr. Zoe Eloise Quandt, Endocrinology, MD graduated from University of California, San Francisco (UCSF), School of Medicine. She completed residency at Stanford University Medical Center. She is certified by the American Board of Internal Medicine, Endocrinology Diabetes & Metab and has a state license in California.
Medical School: University of California, San Francisco (UCSF), School of Medicine
Residency: Stanford University Medical Center
Board Certification: American Board of Internal Medicine, Endocrinology Diabetes & Metab
Licensed In: California
Dr. Zoe Eloise Quandt, Endocrinology, MD is associated with these hospitals and organizations:
Dr. Zoe Eloise Quandt, Endocrinology, MD appears to accept the following insurance providers: Cigna, Aetna, Blue Shield of California, Anthem, UnitedHealthcare, Health Net, Central Health Plan, CCHP Health Plan (Chinese Community Health Plan) and Canopy Health.
According to our sources, Dr. Zoe Eloise Quandt, Endocrinology, MD accepts the following insurance providers:
Dr. Zoe Eloise Quandt, Endocrinology, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 75 ratings. We collect ratings and reviews of Dr. Zoe Eloise Quandt, Endocrinology, MD from all over the web to help you find the right in San Francisco, CA.
These charts describe general payments received by Dr. Zoe Eloise Quandt, Endocrinology, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Novartis Pharmaceuticals Corporation |
$8,289
PIQRAY $6,746 |
$1,544 |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC |
$6,319
TZIELD $6,319 |
|
| Medtronic MiniMed, Inc. |
$213
Minimed 670G System $35 |
$178 |
| Consulting Fee | $14,377 |
|---|---|
| Food and Beverage | $266 |
| Education | $178 |
Dr. Zoe Quandt is a specialist in endocrinology. She works in San Francisco, CA, Stanford, CA, and Los Angeles, CA. Her average rating from her patients is 5.0 stars (out of 5). She is an in-network provider for several insurance carriers, including Blue Shield, Health Net, and Anthem. Dr. Quandt studied medicine at the University of California, San Francisco (UCSF), School of Medicine. For her residency, Dr. Quandt trained at Stanford University Medical Center. Dr. Quandt is professionally affiliated with UCSF Medical Group, Hill Physicians, and Regents of the University of California. According to Hill Physicians, she is not acceping new patients at this time.